Medistim Announces Launch of MiraQ INTUI Software Platform

Medistim’s devices for Transit Time Flow Measurement (TTFM) and High-Frequency Ultrasound (HFUS) are currently utilized in approximately 37% of the 700,000 coronary artery bypass graft (CABG) procedures performed worldwide each year. While TTFM is already the standard of care in many European and Asian countries, significant growth opportunities remain in key markets such as the United States. Driving global adoption and establishing routine use will depend on continued product innovation, focusing on enhanced user-friendliness and delivering greater clinical value.

Built on a cutting-edge, future-proof software architecture, INTUI sets a new standard for Medistim’s MiraQ™ technology. Its redesigned user interface is engineered to enhance procedural efficiency in surgery, offering simplified navigation, quicker access to critical data, and improved data interpretation—ultimately streamlining workflow and optimizing performance.

“Developed and tested in collaboration with an international team of cardiac surgeons, we are confident that INTUI offers advanced support for clinical decision-making, with the potential to improve patient safety and outcomes,” said Kari E. Krogstad, President and CEO of Medistim. “Our mission is to equip surgical teams with tools that simplify complex procedures, delivering exceptional ease of use. And this is just the beginning—we are excited to expand this technology to vascular applications in the near future.”